(Q44007043)

28 November 2017

title

Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice (English)

1 reference

28 November 2017

0 references

3

1 reference

28 November 2017

6

Matthias Endres

1 reference

28 November 2017

Ulrich Laufs

1

1 reference

28 November 2017

Karen Gertz

series ordinal

2

1 reference

28 November 2017

Michael Böhm

series ordinal

4

1 reference

28 November 2017

Georg Nickenig

series ordinal

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

942

1 reference

28 November 2017

issue

1-2

1 reference

28 November 2017

page(s)

23-30

1 reference

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Pharmacology of competitive inhibitors of HMG-CoA reductase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Vascular effects of statins in stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

DNA methyltransferase contributes to delayed ischemic brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Neuroprotective effects of gelsolin during murine stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Regulation of the mevalonate pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Hypertension in mice lacking the gene for endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Neuroprotection mediated by changes in the endothelial actin cytoskeleton.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Molecular biology of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Current perspectives on statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902649-5

10.1016/S0006-8993(02)02649-5

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference